Quick Takeaways
- Parag Saxena filed SCHEDULE 13D/A for REVIVA PHARMACEUTICALS HOLDINGS, INC. Common Stock, $0.0001 par value (RVPH).
- Disclosed ownership: 8.7%.
- Date of event: 27 Jun 2025.
Parag Saxena - 27 Jun 2025 SCHEDULE 13D/A Report for REVIVA PHARMACEUTICALS HOLDINGS, INC. Common Stock, $0.0001 par value (RVPH)
- Filing Manager
- Parag Saxena
- Reporting Manager
- Parag Saxena
- Symbol
- RVPH
- Shares outstanding
- 71,951,793 shares
- Disclosed Ownership
- 6,259,806 shares
- Ownership
- 8.7%
- Form type
- SCHEDULE 13D/A
- Filing time
- 01 Jul 2025, 18:40:00 UTC
- Date of event
- 27 Jun 2025
- Previous filing
- 31 Jan 2025
- Next filing
- 24 Sep 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Parag Saxena disclosed 8.7% ownership in REVIVA PHARMACEUTICALS HOLDINGS, INC. Common Stock, $0.0001 par value (RVPH) on 27 Jun 2025."
What Changed
- Previous schedule filing date: 31 Jan 2025.
- Current filing was accepted on 01 Jul 2025, 18:40.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Vedanta Associates, L.P. | 4.8% | 3,408,401 | 0 | 3,408,401 | By: Vedanta Partners, LLC, the GP of Vedanta Associates, L.P. /s/ Parag Saxena | Parag Saxena/CEO of Vedanta Partners, LLC | 0001502222 |
| VEDANTA PARTNERS, LLC | 7.5% | 5,367,069 | 0 | 5,367,069 | /s/ Parag Saxena | Parag Saxena/CEO | 0001502216 |
| Parag Saxena | 8.7% | 6,259,806 | 892,737 | 5,376,169 | /s/ Parag Saxena | Parag Saxena/Individual | 0001015823 |